Knopka is an advanced call system for hospitals and care homes to notify nurses and help them respond immediately when a patient needs help. The Knopka alarm button connects wirelessly to the Movesense Medical sensor to automatize certain nurse call triggers. The system is developed by the Ukrainian medtech startup Knopka (“Button” in Ukrainian). Knopka […]
We are happy to announce that the new Movesense sensor firmware 2.1.5 is now available for both Movesense MD and non-medical Movesense sensors. This version corrects the bug found in the version 2.1.3 which may have caused loss of ECG data in certain specific usage scenarios. In addition, two other bugs were fixed. Access the […]
Portable single-channel ECG devices offer an efficient atrial fibrillation (Afib) screening alternative to 24-hour Holter monitoring.1 The new MDR certified chest strap ECG monitor Movesense Medical concretizes the benefits that this product category offers to improve healthcare efficiency. Movesense Medical is a lightweight ECG and movement sensor developed by the Finnish wearable technology expert Movesense. […]
Vantaa, Finland — The Movesense Medical wearable ECG and movement sensor, developed by the Finnish medical device manufacturer Movesense Ltd, has been certified as a Class IIa medical device in conformity with the European Medical Device Regulation 2017/745 (MDR). Movesense Medical sensor is a lightweight wearable sensor intended for measuring single channel ECG, heart rate, […]
The Spanish health tech company Ephion Health recently published a monitoring system to measure gait biomechanics in Duchenne Muscular Dystrophy (DMD) patients using wearable sensors. The system integrates eight commercial wearables. It consists of five Movesense Medical sensors for inertial measurement, one of which also measures heart rate, two plantar pressure insoles from Moticon and […]
As communicated in our earlier news updates, we are going through the MDR conformity assessment of Movesense MD sensor. The new EU Medical Device Regulation 2017/745 (MDR) is replacing the Medical Device Directive MDD 93/42/EEC (MDD). Compliance with the MDR is mandatory for all new medical devices introduced to the EU market, and all existing […]
Movesense team’s year 2022 culminated in mid-December with the second stage audit of the MDR certification of the Movesense Medical ECG and movement sensor. We are pleased to note that the process continues as planned. The new EU Medical Device Regulation 2017/745 (MDR) is replacing the Medical Device Directive MDD 93/42/EEC. Compliance with the MDR is […]
Medica 2022 trade fair is over and it’s time to summarize our observations related to digital health trends and topics. Movesense exhibited in the Hall 12 that collected wearable device brands, start-ups, health IT companies and other innovators in digital healthcare. There were two leading themes that caught the attention at the show: The digitalization […]
Movesense is delighted to announce that the MDR conformity assessment process of the Movesense Medical ECG and movement sensor is proceeding as scheduled. The first phase of the assessment was completed in October 2022. The team is now working on the next steps, aiming for the process finalization in a timely manner. Movesense Medical classification […]
Biosensors for Medical Wearables is a compact conference with a laser-sharp focus on wearable medical sensors. The event brought together pharmaceutical companies, medical device developers and component manufacturers to Boston on Oct 24-25 to explore key drivers and innovations of the rapidly expanding wearable medical biosensors market. Movesense was one of the event partners, represented […]
The worldwide largest trade fair for the medical sector, MEDICA 2022 brings nearly 100000 visitors and thousands of exhibitors from all over the world to Düsseldorf, Germany, on November 14-17. For four days, Medica is the place to see where the healthcare industry is going and the latest innovations in medical products and technologies. If […]
Biosensors for Medical Wearables brings together big pharma, device developers and component manufacturers to explore the key drivers and innovations of the wearable medical biosensors landscape. Movesense is exited to partner with the event to spread the word about the possibilities that Movesense sensors offer in this context. The global market for wearable biosensors is […]
We are extremely excited to announce that Movesense Ltd has been granted ISO 13485:2016 medical device quality management system certificate. The quality management system of Movesense was audited and certified by Eurofins Electric & Electronics Finland Ltd. ISO 13485:2016 standard specifies requirements for a quality management system that can be used by an organization involved […]
Movesense sensor allows researchers to create a new method for assessing the neurological development of young children. Early motor assessment is essential for supporting the early detection of neurodevelopmental problems and their therapeutic interventions. Photo: Helsinki University A Finnish research group at the BABA Center, Helsinki Children’s Hospital, has developed a novel wearable for infants […]
Clinical multi-lead ECG systems, e.g., Holter ECGs, are expensive, involve considerable participant and researcher burden and are not practical for field base monitoring in active populations.[i] The new ECG monitors with a chest strap form factor offer many benefits for monitoring certain heart parameters and cardiac health. Especially for long-term monitoring of heart rate variability […]
The sensor firmware for Movesense Medical takes a major leap ahead with the newly published 2.1.3 version that covers all Movesense sensor variants and is approved for medical use. The previous firmware version for Movesense MD was 1.9.5.1. After the 1.9.5.1 release, we have published several non-medical firmware updates. After extensive testing and field use […]
A scientific study finds high correlation between the heart rate variability parameters measured with Movesense Medical and a gold standard 12-lead ECG monitor. The study concludes that Movesense Medical can be used instead of a reference ECG for the calculation of HRV. According to the study, Movesense Medical represents a significant advance in both a […]
Kaasa solution GmbH is a German software company and a highly active member of the Movesense ecosystem. Kaasa is offering its expertise to Movesense customers who need software resources for their own projects, but the company also has its own products, many of which help developers and researchers to use Movesense sensors efficiently. Kaasa is […]
Atrial fibrillation, also called AFib or AF, is the most common type of treated heart arrhythmia. AF increases a person’s risk for stroke. Strokes caused by complications from AF are usually more severe than strokes with other causes. However, with timely detection and treatment of AF, the stroke risk can be remarkably reduced. The risk […]
With the fast evolution of health technology and wearable devices, the range of health-related products that are available for consumers and private use is increasing rapidly. Medically regulated products are quickly becoming as accessible for consumers as easily as ordinary, unregulated consumer electronics products. The pressure of rising healthcare costs and the rapid increase of […]
Innovation keeps flourishing in the Movesense developer community. The variety of ideas and concepts that are emerging around the world is amazing. Movesense team is delighted to see all the valuable solutions that the platform is enabling for a variety of needs and problems that we often didn’t even know to exist. To highlight the […]
Heart Sentinel is an Italian health tech start-up that develops algorithms for the prevention of cardiac problems. The Parma-based company has been testing their arrhythmia detection algorithms with Movesense sensors and recently published the results of a study that demonstrates the usefulness of running arrhythmia algorithms locally on the sensor. The report with the title […]
Ainone is a Finnish startup that is developing a lightweight, mobile, rehabilitation and coaching platform for measuring key components of neurological performance. The company is first addressing the need for an easy and cost-effective solution to accurately and objectively measure balance. Balance is an essential measure of performance for athletes, the elderly, and anyone in […]
Heart2Save is a Kuopio Finland based health tech company that was founded in 2015 to solve a specific problem. The founder and CEO of the company Helena Jäntti saw in her work as a emergency doctor many patients who got her thinking of a device that could quickly and reliably detect heart arrhythmias before they […]
Measuring health conditions can bring a host of benefits to patients and healthcare systems, including earlier detection of conditions, more timely intervention, and more effective treatment and rehabilitation. Innovators can run into issues trying to transform their big idea into a healthcare solution though, such as developing and testing new hardware and seeking certification for […]
The world of medicine meets at MEDICA 2021 trade fair in Düsseldorf, Germany on Nov 15-18. It is a must for anyone who wants to experience tomorrow’s healthcare market live. Movesense is exhibiting at the show with our customers Ainone and Heart2Save. Also our software partner Kaasa solution will be there. If you are interested […]
MEDICA 2021, the world’s largest trade show for medical technology, will take place in Düsseldorf, Germany on 15th-18th November. The show will be the first large scale physical meeting of the global medical business community after November 2019. Movesense is exhibiting at MEDICA together with two of our customer companies, Ainone and Heart2Save. Ainone is […]
Heart2Save, Lumoava and Suunto have developed and launched the Awario Gem ECG necklace, which, together with the user’s phone, enables the measurement of a hospital-level ECG (electrocardiogram) at home. Awario Gem helps identify the four most common arrhythmias, the most dangerous of which is atrial fibrillation. Atrial fibrillation causes about 4,500 strokes in Finland every […]
Navispace is calling all health-related Internet of Medical Things (IoMT) start-ups, scale-ups and SMEs to join the 13th Healthcare Innovation World Cup® – the world´s leading open innovation platform in the Internet of Medical Things. The competition promotes innovations, makes them visible to the world, and connects innovators with decision-makers, potential partners, investors and customers. […]
One of the Movesense Academic Program participants, Neurobit Technologies, Singapore, is working on combining sleep staging and respiratory event detection with Movesense sensors to enable sleep disorder assessment at scale. During the project, Neurobit validates its algorithm for detecting sleep stages and Obstructive Sleep Apnea using ECG and motion data from Movesense. The company has […]
Atrial fibrillation – an irregular and often rapid heart rhythm or ‘arrhythmia’ – is an increasingly common condition estimated to affect 7.6 million people over the age of 65 in the EU.1 Patients with atrial fibrillation have a five times higher risk of stroke. In fact, the condition is responsible for between 20 and 30 […]
Movesense Medical sensor is practical tool for developing new wearable solutions for healthcare and wellbeing. It measures heart rate, single channel ECG, and movement with 9-axis inertial measurement unit. The sensor can be programmed to meet the needs of various use cases ranging from clinical assessment to health monitoring in home environment. With roots in […]
Good balance is an essential element of human performance for everyone in daily life and is something most of us take for granted. When balance and movement become impaired though, for instance after a trauma or sports related concussion (SRC), age-related degeneration, lower limb injuries, or osteoarthritis, the impact can be far-reaching. Measuring and understanding […]
We are proud to announce that we have just completed the medical registration process of the Movesense Medical sensor. It is now certified as a medical device accessory, class II a, according to Medical Device Directive 93/42/EEC of the European Union. Movesense Medical is commercially available from the beginning of 2021. To get started with […]
Movesense sensors can be used to monitor heart rate, ECG and movement of a person in field conditions. There are already projects where companies are using these features to detect arrhythmias, to evaluate physiological load and mental stress through heart rate variation, or to monitor chest movement and breathing. Movesense team wants to contribute to […]
A new innovation makes it possible, for the first time, to quantitatively assess children’s spontaneous movement in the natural environment. Researchers have developed a smart jumpsuit to accurately measure the spontaneous and voluntary movement of infants from the age of five months. Details on their motility help in assessing abnormal neurological development, among other things. […]
Suunto Expands its Open Sensor Platform to the Medical Field Press release, VANTAA, Finland—November 8, 2019 —Suunto is making it easier to rapidly develop and bring to market new, accurate, low-cost solutions for motion-sensing and biometrics with Movesense, a sophisticated sensor and development environment. In application areas as diverse as sports, agriculture, manufacturing, and health […]
Heart2Save, a Finnish startup with roots in Kuopio University Hospital, announced a Movesense powered solution that allows the user him/herself to identify atrial fibrillation at an early stage. The company’s ambitious vision is to reduce strokes caused by atrial fibrillation and thus save lives and secure healthier life years. The AiVoni Analysis Service includes a […]
